CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Kamada Ltd.

KMDA
$504MSmall Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for KMDA. That does not mean none is planned.

Get an email about KMDA's next catalysts

Track Kamada (KMDA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 1 past

No catalysts found.

How KMDA's past catalysts played out

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsPharmaceutical🇺🇸North AmericaREHOVOT450 employees

Kamada Ltd. is a global biopharmaceutical company specializing in the research, manufacturing, and commercialization of specialty pharmaceuticals derived from human plasma. The company’s portfolio includes 6 FDA-approved plasma-derived products, which are distributed in over 30 international markets.

Website

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

Frequently asked questions

What is in Kamada Ltd.'s drug pipeline?→

CatalystAlert tracks 12 drug candidates in Kamada Ltd.'s (KMDA) pipeline across Phase 3, Phase 2. Its lead program is Active rabies vaccine (US-FDA approved) (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Kamada Ltd.'s next FDA catalyst?→

CatalystAlert tracks every upcoming catalyst for Kamada Ltd. (KMDA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.

How do I track KMDA biotech catalysts?→

Add KMDA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Kamada Ltd.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply